Progressive formation of inclusions in the striatum and hippocampus of mice transgenic for the human Huntington's disease mutation

Journal of Neurocytology

Volumn 29, Issue 9, 2000, Pages 679-702

  Morton, A J ^a   Lagan, M A ^a   Skepper, J N ^a   Dunnett, S B ^b  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b University of Cambridge   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

POLYGLUTAMINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL NUCLEUS INCLUSION BODY; CELL TYPE; CELLULAR DISTRIBUTION; COGNITION; CONTROLLED STUDY; CORPUS STRIATUM; GENE MUTATION; HIPPOCAMPUS; HUNTINGTON CHOREA; MOUSE; NERVE GROWTH; NONHUMAN; NUCLEOTIDE REPEAT; PHENOTYPE; PRIORITY JOURNAL; SYNAPSE; TRANSGENIC MOUSE;

ANIMALIA; HIPPOCAMPUS HIPPOCAMPUS; MUS MUSCULUS;

EID: 0034958203     PISSN: 03004864     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1010887421592     Document Type: Article

References (50)

1. Characterisation of progressive motor deficits in mice transgenic for the human Huntington's disease mutation
2. Altered brain neurotransmitter receptor expression in transgenic mouse models of Huntington disease gene
3. Evidence for proteasome involvement in polyglutamine disease: Localisation to nuclear inclusions in SCA3/MJD and suppression of polyglutamine aggregation in vitro
4. Mutation of the E6-AP ubiquitin ligase reduces nuclear inclusion frequency while accelerating polyglutamine-induced pathology in SCA1 mice
5. Formation of neuronal intranuclear inclusions (NII) underlies the neurological dysfunction in mice transgenic for the HD mutation
6. From neuronal inclusions to neurodegeneration: Neuropathological investigation of a transgenic mouse model of Huntington's disease
7. Aggregation of huntingtin in neuronal intranuclear inclusions and dystrophic neurites in brain
8. Polyglutamine expansions: Proteolysis, chaperones and the dangers of promiscuity
9. Intranuclear inclusions and the ubiquitin- proteasome pathway: Digestion of a red herring?
10. The neostriatal mosaic: Compartmental distribution of calcium- binding protein and parvalbumin in the basal ganglia of the rat and monkey
11. Filamentous nerve cell inclusions in neurodegenerative diseases
12. Neuronal distribution of intranuclear inclusions in Huntington's disease with adult onset
13. The Nucleator
14. The new stereological tools: Disector, fractionator, nucleator and point sampled intercepts, and their use in pathological research and diagnosis
15. Nuclear and neuropil aggregates in Huntington's disease: Relationship to neuropathology
16. Evidence for both the nucleus and cytoplasm as subcellular sites of pathogenesis in Huntington's disease in cell culture and in transgenic mice expressing mutant huntingtin
17. Rapid aggregate formation of the huntingtin N-terminal fragment carrying an expanded polyglutamine tract
18. Early loss of neostriatal striosome neurones in Huntington's disease
19. Spinocerebellar ataxia type 7 (SCA7): A neurodegenerative disorder with neuronal intranuclear inclusions
20. Mice transgenic for an expanded CAG repeat in the Huntington's disease gene develop diabetes
21. The localisation and interactions of huntingtin
22. More hippocampal neurones in adult mice living in an enriched environment
23. Neuronal intranuclear inclusions in polyglutamine diseases: Nuclear weapons or nuclear fallout?
24. Ataxin-1 nuclear localisation and aggregation: Role in polyglutamine- induced disease in SCA1 transgenic mice
25. Ultrastructural localisation and progressive formation of neuropil aggregates in Huntington's disease transgenic mice
26. Selective discrimination learning impairments in mice expressing the human Huntington's disease mutation
27. Exon 1 of the HD gene with an expanded CAG repeat is sufficient to cause a progressive neurological phenotype in transgenic mice
28. Length of huntingtin and its polyglutamine tract influences localisation and frequency of intracellular aggregates
29. Alpha-synuclein immunoreactivity o huntingtin polyglutamine aggregates in striatum and cortex of Huntington's disease patients and transgenic mouse models
30. Compartmental loss of NADPH diaphorase in the human striatum in Huntington's disease
31. Abnormal synaptic plasticity and impaired spatial cognition in mice transgenic for the human Huntington's disease mutation
32. Expanded polyglutamine domain proteins bind neurofilament and alter the neurofilament network
33. Inhibition of caspase-1 slows disease progression in a mouse model of Huntington's disease
34. Ectopically expressed CAG repeats cause intranuclear inclusions and a progressive late onset neurological phenotype in the mouse
35. Recruitment and the role of nuclear localisation in polyglutamine-mediated aggregation
36. Polar zippers - Their role in human disease
37. Intranuclear inclusions of expanded polyglutamine protein in spinocerebellar ataxia type 3
38. Recent advances in understanding the pathogenesis of Huntington's disease
39. Brain neurotransmitter deficits in mice transgenic for the Huntington's disease mutation
40. Caspase-8 is required for cell death induced by expanded polyglutamine repeats
41. Huntingtin acts in the nucleus to induce apoptosis but death does not correlate with the formation of intranuclear inclusions
42. Huntingtin-encoded polyglutamine expansions form amyloid-like protein aggregates in vitro and in vivo
43. Nuclear inclusions in glutamine repeat disorders: Are they pernicious, coincidental, or beneficial?
44. SH3GL3 associates with the huntingtin exon 1 protein and promotes the formation of poly gln-containing protein aggregates
45. Polyglutamine-expanded androgen receptors form aggregates that sequester heat shock proteins, proteasome components and SRC-1, and are suppressed by the HDJ-2 chaperone
46. The unbiased estimation of number and sizes of arbitrary particles using the disector
47. Neuropathologic classification of Huntington's disease
48. Expanded polyglutamine protein forms nuclear inclusions and causes neural degeneration in Drosophila
49. Reversal of neuropathology and motor dysfunction in a conditional model of Huntington's disease